Saxagliptin and Heart Failure in the SAVOR-TIMI 53 Trial: Reflections on the Bradford Hill Criteria.
Sign Up to like & getrecommendations! Published in 2017 at "Revista espanola de cardiologia"
DOI: 10.1016/j.rec.2017.02.023
Abstract: tropic medications: a proposal for clinical management. Eur Heart J. 2014;35:1306–1315. 4. Ficha técnica. Centro de Información online de Medicamentos de la AEMPS – CIMA [accessed 1 Jun 2016]. http://www.aemps.gob.es/cima/fichasTecnicas. do?metodo=buscar. 5. Buenas prácticas en… read more here.
Keywords: timi trial; heart; savor timi; saxagliptin heart ... See more keywords
Hypoglycaemia manifestations and recurrent events: Lessons from the SAVOR‐TIMI 53 outcome study
Sign Up to like & getrecommendations! Published in 2017 at "Diabetes"
DOI: 10.1111/dom.12903
Abstract: Hypoglycaemia is a well‐known risk associated with the use of sulphonylureas and insulin, often limiting achievement of glycaemic goals. Recognizing the precipitants and recurrence patterns of hypoglycaemic events, particularly major events, is therefore clinically important.… read more here.
Keywords: hypoglycaemic events; savor timi; study; event ... See more keywords
Assessing reproducibility and utility of clustering of patients with type 2 diabetes and established CV disease (SAVOR -TIMI 53 trial)
Sign Up to like & getrecommendations! Published in 2021 at "PLoS ONE"
DOI: 10.1371/journal.pone.0259372
Abstract: Objective To assess the reproducibility and clinical utility of clustering-based subtyping of patients with type 2 diabetes (T2D) and established cardiovascular (CV) disease. Methods The cardiovascular outcome trial SAVOR-TIMI 53 (n = 16,492) was used.… read more here.
Keywords: savor timi; clustering based; established disease; disease ... See more keywords